Occlutech, a leading European innovator of products to treat structural heart disease today announced that it is making its range of PFO and ASD occluders available on the South Korean market.
Tor Peters, CEO of the Occlutech Group, commented: "We are very pleased to provide patients and cardiologists in South Korea with our unique and innovative products. With our local partner, we are now creating a presence with sales and clinical specialists all over South Korea."
Occlutech products are already available throughout Asia-Pacific and sold in countries such as Australia, New Zealand & Taiwan. During the next few years, approvals are expected in Japan and China.
Occlutech's PFO and ASD occluders consist of a flexible Nitinol wire mesh with "shape-memory" properties. The implants are available in different configurations, multiple sizes, and can accommodate a broad range of anatomies.
Cardiac damage framework may identify patients who could benefit from earlier TAVR